Can Boston Scientific Stock Bounce Off This Support Again?

Oct 22, 2026
can-boston-scientific-stock-bounce-off-this-support-again?

Image from Unsplash

For questions about this article or underlying research, email help@trefis.com.

Boston Scientific (BSX) shareholders have lost more than half their money over the past year. The stock posted a total return of -54.1%, compared with 17.1% for the S&P 500. At $45.58, the shares are near the prices where they bounced in 2022, 2023 and July, which ranged from $43.06 to $47.06. So how far have bounces from this price gone, and what could one be worth to you now?

How Far Boston Scientific Stock Has Bounced From Here

Boston Scientific stock has rallied from this price three times since 2022. A bounce starting on October 28, 2022, lifted the shares to a close 26.7% higher within ten months. A second run beginning on February 9, 2023, climbed further to a close 39.2% higher. The latest recovery started on July 1, 2026, and peaked 20.8% higher seven weeks later.

If the shares bounce again, they will first face resistance at $52.01, the point where the July rally stopped. The table below shows only the higher level. Further resistance sits at $57.78, where an earlier rally stalled. At that higher price, a $10,000 investment made today would be worth about $12,680. Measured over a full year, the two earlier bounces gained 26.7% and 39.2%. At the 33.0% midpoint of those gains, the same purchase would be worth about $13,300. However, those figures track only the successful rebounds. Over the two years since October 15, 2024, the stock has fallen into this price band from above three times, and each time it dropped a further 5% before it could rise 20%. The July rally itself started just below this band at $43.06.

One stock can move your whole plan when it is a large share of what you own. See how to protect a concentrated position.

Is Boston Scientific’s Business Strong Enough For A Bounce?

Boston Scientific continues to grow and earn more, but its sales are expanding at a slower pace than its historical record. Revenue rose 13.5% over the twelve months ended June 30, 2026, falling short of the 16.2% average across the prior three such periods. The operating margin has risen each year, climbing from 17.8% in the twelve months ended June 2024 to 18.3% a year later. The operating margin then reached 21.0% in the latest twelve months, marking a ten-year high. The shares trade at 18.2 times earnings, compared with 23.0 for the S&P 500.

Leave a comment